Aquacoat® ECD for Sustained Release and Aquacoat® CPD for Enteric Coating Applications

aquacoat aquacoat

Aquacoat® ECD is an aqueous colloidal dispersion of ethylcellulose polymer. In sustained release applications, Aquacoat® ECD offers stable, reproducible, pH-independent release profiles. Its primary release mechanism is drug diffusion across a water-insoluble membrane.

Addition of plasticizer is required for use, and the type and level of addition based on the permeability and, in turn, the drug release profile required. Recommended levels are 20-25% of plasticizer content based on ethylcellulose solid content levels.

Aquacoat® CPD is an aqueous dispersion based on cellulose acetate phthalate.  Provides enteric coating protection for tablets and capsules. Plasticiser addition is required, at levels of approx. 24%.

  • Acceptable for pharmaceutical use in the U.S. and Europe
  • GRAS status for food in America

Aquacoat® is a trademark of International Flavors and Fragrances Inc. or its affiliates. 

© 2021 IFF.  All rights reserved 

Platform Solutions

Colorcon can help to reduce your project time by providing the right solution through excipient selection and process guidance.


Lower total cost and reduce time to market

solution productivity 2021

Dissolution Design

Life cycle management through modified delivery profiles and product line extensions


Patient Adherence

Reduce medication errors and improve patient adherence

solutions patient compliance 2021


Stable and consistent product performance

solution stability 2021

Product Authentication

Track and trace

authentication 1